These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 10662)
21. [The inhibition of thrombocyte aggregation in vitro and in vivo]. Breddin K Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(4):460-9. PubMed ID: 4193162 [No Abstract] [Full Text] [Related]
22. The effect of antiadhesive drugs on platelet function and metabolism. Ulutin SB; Yaramanci TE; Ulutin ON Acta Univ Carol Med Monogr; 1972; 53():237-46. PubMed ID: 4670732 [No Abstract] [Full Text] [Related]
24. Bradykinin induced bronchoconstriction in guinea pigs and its modification by various agents. Simke J; Graeme ML; Sigg EB Arch Int Pharmacodyn Ther; 1967 Feb; 165(2):291-301. PubMed ID: 4382225 [No Abstract] [Full Text] [Related]
25. Platelets and drugs. Sheehy TW J Med Assoc State Ala; 1976 Apr; 45(9):29-34. PubMed ID: 1031175 [No Abstract] [Full Text] [Related]
26. Effects of drugs on platelet function. Morse EE Ann Clin Lab Sci; 1977; 7(1):68-72. PubMed ID: 189670 [TBL] [Abstract][Full Text] [Related]
27. Suloctidil: a novel inhibitor of platelet aggregation in human beings. de Gaetano G; Miragliotta G; Roncucci R; Lansen J; Lambelin G Thromb Res; 1976 Mar; 8(3):361-71. PubMed ID: 1265708 [No Abstract] [Full Text] [Related]
28. Mechanism of platelet aggregation and release: their possible role in vascular injury. Ardlie NG Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):891-905. PubMed ID: 4610504 [No Abstract] [Full Text] [Related]
29. [Antiaggregants of thrombocytes in ischemic heart disease]. Beloev I ; Tomov I; TŭrnovskaR Vutr Boles; 1985; 24(5):1-6. PubMed ID: 2868572 [No Abstract] [Full Text] [Related]
30. Platelet aggregation by Thrombofax. de Gaetano G; Vermylen J; Verstraete M Acta Univ Carol Med Monogr; 1972; 53():391-8. PubMed ID: 4670744 [No Abstract] [Full Text] [Related]
32. Chemical induction of fibrinolysis and inhibition of platelet aggregation (with special respect to effect of nonsteroid antiinflammatory drugs). Cepelák V; Roubal Z; Cepeláková H; Nĕmecek O Acta Univ Carol Med Monogr; 1972; 52():41-7. PubMed ID: 4669825 [No Abstract] [Full Text] [Related]
33. The effect of agents which modify platelet behaviour and of magnesium ions on thrombus formation in vivo. Adams JH; Mitchell JR Thromb Haemost; 1979 Aug; 42(2):603-10. PubMed ID: 505367 [TBL] [Abstract][Full Text] [Related]
34. Effect of anti-inflammatory agents on platelets. O'Brien JR Lancet; 1968 Apr; 1(7548):894-5. PubMed ID: 4171493 [No Abstract] [Full Text] [Related]
35. [Inhibition of blood platelet function]. Glusa E Z Gesamte Inn Med; 1979 Jan; 34(1):17-22. PubMed ID: 34940 [TBL] [Abstract][Full Text] [Related]
38. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques. Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511 [TBL] [Abstract][Full Text] [Related]
39. Beta-benzal-butyric acid, a new anti-adhesive drug. Mannucci PM; Maggi CA; Gioventu M; Marchi E; Terruzzi AB Acta Univ Carol Med Monogr; 1972; 53():409-12. PubMed ID: 4670746 [No Abstract] [Full Text] [Related]
40. Drug influence on platelet loss during extracorporeal circulation. Mielke CH; de Leval M; Hill JD; Macur MF; Gerbode F J Thorac Cardiovasc Surg; 1973 Dec; 66(6):845-54. PubMed ID: 4759692 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]